2021 Shown to be Terrible Year for Overturns of Accelerated FDA Approvals in Oncology.

If the controversial Alzheimer’s drug approval hasn’t changed your mind about our misunderstanding of FDA approvals, then make sure you read this article from VIVIO team member Bishal Gyawali.